Shanghai, China · Founded 2020 · Privately Held (backing)
Researcher of immune cell drugs designed for tumour patients. Enkai Cell Technology is based in Shanghai, China and was founded in 2020. It has raised $28.9 million.
Last price · $/share
—
Implied valuation
—
Total raised
$28.9M
Last round
—
Team — not yet on record
No current team members for Enkai Cell Technology are on record yet. People surface from round filings, company disclosures, and coverage sessions.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Enkai Cell Technology with a free account
·The complete investor list: 11 names
·Watch Enkai Cell Technology: the Monday email on marks, rounds and moves
